Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients

Organ shortage and waiting list mortality have led to changes in the allocation policy in Eurotransplant.

To identify factors influencing the survival of liver transplanted patients with model for end-stage liver disease (MELD) score of 40.

Data of listed adult patients who reached a MELD score 40 in the period 12/2006–06/2010 were reviewed. Donor/graft and recipient characteristics, and operative details were analyzed. Statistical analysis encompassed Kaplan–Meier analysis/log-rank test as well as univariate and multivariable regression analyses.

Forty-eight patients achieved a MELD score 40. Thirty patients were transplanted, whereas 18 patients were not. Three-month, 1-year, and 5-year patient and graft survival for transplanted patients was 53, 50, and 47 %, respectively. Three-month and 1-year survival after listing was 11 and 6 % for not transplanted patients, respectively (p < 0.0001). Multivariable analysis revealed pre-operative dialysis (p = 0.0246) and portal vein thrombosis (PVT) (p = 0.0231) to be independent prognostic factors for post-transplant patient survival. A point scoring system was created, which reached statistical significance (p = 0.0007). One-year and 5-year survival for scores 0, 1, and 2 were 72 and 64, 42 and 42 and 0 %, respectively. There was no statistical difference in transplantation costs between patients who survived or died (p = 0.1578).

At our center, coexistence of pre-operative dialysis and PVT represents a clear contraindication for LT regarding MELD score 40 patients.